CFMS logo

Conformis (CFMS) Stock

Profile

Full Name:

Conformis, Inc.

Sector:

Healthcare

Country:

United States

IPO:

01 July 2015

Indexes:

Not included

Description:

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 02, 2023

Recent annual earnings:

Mar 02, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 10, 2022

Analyst ratings

Recent major analysts updates

09 May '23 Oppenheimer
Perform
11 Nov '22 Oppenheimer
Outperform
04 Nov '21 Oppenheimer
Outperform
22 Sept '21 Oppenheimer
Outperform
12 May '20 Oppenheimer
Outperform
02 Apr '19 Oppenheimer
Outperform
01 Nov '18 Canaccord Genuity
Buy
05 May '18 B. Riley FBR
Buy
10 Apr '18 Canaccord Genuity
Buy
21 Feb '18 Cowen & Co.
Outperform

Screeners with CFMS included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
CFMS
Zacks Investment Research08 May 2023

ConforMIS (CFMS) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $2.25 per share a year ago.

Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
CFMS
Seeking Alpha08 May 2023

Conformis, Inc. (NASDAQ:CFMS ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participants Eric Anderson - TD Cowen Steve Lichtman - Oppenheimer Joshua Jennings - TD Cowen Operator Good morning, and welcome to the First Quarter 2023 Earnings Conference Call for Conformis, Incorporated. My name is Tanya, and I will be your conference operator today.

FAQ

  • What is the primary business of Conformis?
  • What is the ticker symbol for Conformis?
  • Does Conformis pay dividends?
  • What sector is Conformis in?
  • What industry is Conformis in?
  • What country is Conformis based in?
  • When did Conformis go public?
  • Is Conformis in the S&P 500?
  • Is Conformis in the NASDAQ 100?
  • Is Conformis in the Dow Jones?
  • When was Conformis's last earnings report?
  • When does Conformis report earnings?
  • Should I buy Conformis stock now?

What is the primary business of Conformis?

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

What is the ticker symbol for Conformis?

The ticker symbol for Conformis is NASDAQ:CFMS

Does Conformis pay dividends?

No, Conformis does not pay dividends

What sector is Conformis in?

Conformis is in the Healthcare sector

What industry is Conformis in?

Conformis is in the Medical Devices industry

What country is Conformis based in?

Conformis is headquartered in United States

When did Conformis go public?

Conformis's initial public offering (IPO) was on 01 July 2015

Is Conformis in the S&P 500?

No, Conformis is not included in the S&P 500 index

Is Conformis in the NASDAQ 100?

No, Conformis is not included in the NASDAQ 100 index

Is Conformis in the Dow Jones?

No, Conformis is not included in the Dow Jones index

When was Conformis's last earnings report?

Conformis's most recent earnings report was on 2 November 2023

When does Conformis report earnings?

The date for Conformis's next earnings report has not been announced yet

Should I buy Conformis stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions